CA2280416A1 - Remotely operable stent - Google Patents

Remotely operable stent Download PDF

Info

Publication number
CA2280416A1
CA2280416A1 CA002280416A CA2280416A CA2280416A1 CA 2280416 A1 CA2280416 A1 CA 2280416A1 CA 002280416 A CA002280416 A CA 002280416A CA 2280416 A CA2280416 A CA 2280416A CA 2280416 A1 CA2280416 A1 CA 2280416A1
Authority
CA
Canada
Prior art keywords
stmt
stent
expansion
actuators
remotely
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002280416A
Other languages
French (fr)
Inventor
Richard C. Fuisz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biovail Technologies Ltd
Original Assignee
Fuisz Technologies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US09/046,175 priority Critical patent/US5972029A/en
Application filed by Fuisz Technologies Ltd filed Critical Fuisz Technologies Ltd
Priority to EP99650069A priority patent/EP1077049A1/en
Priority to JP22990699A priority patent/JP3169943B2/en
Priority to CA002280416A priority patent/CA2280416A1/en
Publication of CA2280416A1 publication Critical patent/CA2280416A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/92Stents in the form of a rolled-up sheet expanding after insertion into the vessel, e.g. with a spiral shape in cross-section

Abstract

A remotely operable stent is disclosed which is radially expandable and contractable along the longitudinal length of the stent. Once the stent is positioned within a body lumen requiring radial support, an actuator and expansion/contraction element increase the radial dimension of the stent along the stent's longitudinal length to provide such support. The stent is remotely operable in vivo using a remote activation system such that the radial dimension of the stent can be changed without the need to re-enter the body lumen.

Description

Attorney Docket: 0008.P.US
REMOTELY OPERABLE STENT
This application is a continuation-in-part of U. S. application Serial No.
08/854,927, filed May 13, 1997, now abandoned.
Field of the Invention The present invention relates to medical stems and more specifically to a stent that is expandable and contractable via remote means after insertion in vivo.
Background of the Invention In many clinical situations, a lumen in a human or animal body, such as a blood vessel or a urinary tract, can require internal support to ensure proper fluid flow. Support for a lumen can be provided by implantation of a stmt in the lumen, which can maintain the radial integrity of the lumen.
A stmt is typically a tubular metallic or polymeric body, which is carried on a dilatation catheter to a specific vascular location. The implantation of a stmt to maintain patency of a body lumen is well known in the art. In one cardiovascular application. a stmt is mounted on a balloon catheter and positioned at the appropriate site within an artery. The balloon is dilated to expand the stent against the vascular wall.
The balloon is thereafter deflated and removed, leaving the expanded stmt in place in the artery. Due to the structural integrity of the stmt, the arterial wall is supported by the stmt and prevented from recollapsing. An example of this method is described in U.S. Patent No.
5,292,321 which is herein incorporated by reference. The stmt may also be expandable via thermal energy through the use of electrical activation or radio-frequency electromagnetic irradiation, as described in U.S. Patent No. 5,562,641.
Several difficulties are associated with the positioning and use of the above-identified stems. For example, it is difficult to simultaneously maintain the radial rigidity and the longitudinal flexibility of the stent to facilitate proper stent delivery. Additionally, the rapid expansion of the stmt by such methods can injure the lumen to be protected, often leading to restenosis in the vessel lumen. Ideally, a stent would be expanded slowly over a prolonged period of time to reduce the likelihood of such injury and resulting restenosis.
Furthermore, it has been discovered that over time the movement, activity and changing medical condition of a patient can adversely affect stmt operation and/or dictate that a previously expanded stmt be further expanded to continue and/or augment the beneficial support provided by the stmt. Currently used stems are not capable of prolonged expansion since they are not expandable in vivo, after removal of the positioning catheter; similarly, stmt expansion after removal of the positioning catheter cannot be accomplished without re-entry into the lumen.
Accordingly, there remains a need in the art for a stmt that can be remotely expanded or contracted in vivo over a prolonged period of time.
Summary of the Invention
2 0 The present invention is directed towards a stent that is remotely expandable or contractable in vivo over a prolonged period of time following stmt implantation.
The stmt of the present invention comprises a radially cylindrical body portion.
Located at one or more locations along its longitudinal length is one or more actuators drivingly associated with one or more expansion/contraction elements that serve to expand 2 5 or contract the stmt's diameter. In a preferred embodiment, the stmt is manufactured and sized such that in a completely relaxed state (i.e., when no radial pressure is exerted on the main body of the stmt) the stmt is at its largest radial dimension. When the one or more expansion/contraction elements are activated by means of one or more signals to the one or more actuators, the main body is reduced/increased in radial dimension in direct proportion to the amount of pressure exerted by the activation of the expansion/contraction elements.
In another embodiment of the present invention, the stmt is manufactured and sized such that in a completely relaxed state the stmt exhibits its smallest radial dimension.
In this embodiment the one or more expansion/contraction elements apply radial pressure from within the main portion of the stmt. When the expansion/contraction elements are 1 o actuated by means of one or more signals received by the one or more actuators, the main body is increased/reduced in radial dimension in direct proportion to the amount of pressure exerted by the activation of the expansion/contraction elements.
In both of the above-identified embodiments, the one or more expansion/contraction elements are remotely operable by the activation of one or more actuators by any one of a number of remote means such as electromagnetic radiation, including radio frequency (RF) energy and infrared remote activation and control systems.
In use, the remotely operable stmt of the present invention is prepared for insertion into the body lumen requiring physical radial support by adjusting the size of the main body of the stmt. If the embodiment includes the stmt manufactured and sized to have its 2 0 largest radial dimension when in a completely relaxed state, this is accomplished by actuating the actuators) which in turn drive, or activate the expansion/contraction elements to apply radial pressure to the external surface of the main body of the stmt, thus reducing the radial dimension of the stmt. This reduction is continued until the radial dimension of the stmt is small enough to allow the stent to pass through the path of the 2 5 body lumen and to be positioned appropriately, at which point the activation signals are terminated. In the second embodiment, when the stmt is manufactured and sized to have its smallest radial dimension when in a completely relaxed state, the natural state of the stmt is appropriate for insertion and thus actuation of the one or more actuators drivingly associated with the expansion/contraction is not required.
Once positioned within the body lumen, the main body of the stmt is expanded or contracted by transmitting the activation signals) to the actuators) which control the expansion/contraction elements to remove or add radial pressure and thereby to provide more or less radial support. The main body of the stmt is expanded to its initial configuration (i.e., either slightly expanded, or alternatively, expanded to its full radial dimension), depending upon the needs of the patient, the condition of the body lumen requiring support and other factors.
Once the remotely operable stent of the present invention is in the initial configuration, the insertion procedure is completed. Subsequently, unlimited adjustments to the stmt's initial configuration can be accomplished via remote means, without additional invasive means. Accordingly, the stmt can be incrementally expanded over a prolonged period of time to reduce the chance of injury or rupture to the lumen to be supported. Additionally, as the activity and/or condition of the patient warrants, adjustments to the stent's initial configuration can be made without the need to re-enter or otherwise access the lumen.
2 0 Brief Description of the Drawings For a more complete understanding of the present invention and the advantages thereof, reference is now made to the following description taken in conjunction with the accompanying drawings in which:
FIGURE 1 is a side view of the remotely operable stmt of the present invention;

FIGURE 2 is a side view, partially in section, of the remotely operable stmt of the present invention within a body lumen including stenosis;
FIGURE 3 is a side view, partially in section, of the remotely operable stmt of the present invention having an initial configuration within a body lumen;
FIGURE 4 is a side view, partially in section, of the remotely operable stmt of the present invention within a body lumen, in a configuration different than its initial configuration; and FIGURE 5 is a block diagram of the remote activation system.
Detailed Description of the Preferred and Alternative Embodiments Refernng to FIGURE 1, there is shown a stmt 10 incorporating the features of the preferred embodiment of the present invention. The stmt 10 generally comprises a radially cylindrical or tubular main body portion 12 comprising a medical grade, relatively flexible but generally shape-retaining material. Preferred materials include Ni-Ti binary alloy ("nitinol"), Ni-Ti-X (X being V, Co, Cu, Fe) ternary alloy, Cu-Zn-A1 ternary alloy, 1 S and Cu-Al-Ni ternary alloy. Alternatively, the stmt can comprise a plastic that is preferably bioabsorbable, biodegradable, biocompatible, non-thrombogenic and sterilizable. The plastic stmt is preferably made singly or of a combination of polymers such as polyactide, polyglycolide, polyactide-co-glycolide polydioxanone, polyethylene, polyiminocarbonates, polycaprolactone, polyesters and like materials.
Polymeric stems 2 0 can be provided with relatively fluid impenetrable walls, or porous walls such as to allow drug delivery, as will be apparent to one of skill in the art.
Located along the longitudinal length of the main body portion 12 are one or more actuators 14. The actuators) 14 is drivingly associated with one or more expansion/contraction elements 16 in a manner known in the art, such that the stmt is 2 5 expanded/contracted in response to one or more signals or movements from the one or more actuators) which itself is activated in response to one or more signals or other external (outside the lumen) activation processes from an external control source. In a preferred embodiment, a plurality of expansion/contraction elements 16 define bands around the main body 12 that are positioned external to the main body 12. In either embodiment, the one or more actuators) 14 are drivingly engaged with one or more of the the expansion/contraction elements) 16 in a manner known in the art, such as for example, worm gears or other transrotational transfer means. In response to the actuators) the expansion/contraction elements) 14 exert more or less pressure on the main body portion 12 of the stmt 10, causing the radial dimension of the main body portion 12 of the stmt 10 l0 to increase or decrease. The actuators) 14 that drive the expansion/contraction elements 16 are preferably micro-motors of a type generally known in the art, drivingly coupled, engaged or otherwise associated therewith. For example, Mussivand, et al.
(ASAIO
Journal 41:M253-258, 1995), describe the production of a transcutaneous air-core transformer for use with an implantable ventricular assist device, whereby diaphragm movement of the device is controlled via infrared communications between an external and internal coils. Furthermore, as discussed in U.S. Patent 5,92,037, planar micro-motors and electrically-driven actuators with minimum widths and heights of 20 micrometers or less can be fabricated through the use of well known techniques referred to as microfabrication of miniature devices ("MEMS"), and using well known materials.
2 0 Referring to FIGURE 5, the micro-motor will typically be responsive to an externally generated signal 24, for example an electromagnetic, IR or RF signal, produced by a remote activation system 26, causing actuation of actuator which in turn actuates or drives the expansion/contraction elements 16. Although a micro-motor coupled to an expansion/contraction element is disclosed herein, it is noted that any appropriate actuator 2 5 may be used, to control the movement of the expansion/contraction elements 16, if desired.

It will be obvious to one of ordinary skill in the art that the expansion/contraction elements 16 and the actuators) association/coupling can comprise any of the well known devices for translating input energy from the actuators) into radial pressure or other useful motion, such as disclosed in U.S. 5,92,037 and in Mussivand, et al.
The main body portion 12 of the stmt 10 is generally hollow in nature and is especially flexible along its longitudinal length. In a preferred embodiment of the instant invention, the stmt 10 is manufactured and sized such that the stmt 10 has its largest radial dimension in its relaxed state (i.e., when none of the expansion/contraction elements 16 are exerting radial pressure on the stmt 10). In this embodiment, the expansion/contraction l0 elements 16 apply pressure on the exterior of the main body portion 12 of the stmt 10 in respones to activation of the actuators drivingly associated therewith to decrease the radial dimension of the stmt 10.
In a further embodiment of the instant invention the stmt 10 is manufactured and sized such that such that in a completely relaxed state the stmt 10 has its smallest radial dimension. In this embodiment, the expansion/contraction elements) 16 applies pressure from inside the main body portion 12 of the stmt 10 in response to activation of the actuators) drivingly associated therewith to increase the radial dimension of the stent 10.
The actuators) 14 is controlled remotely via any suitable remote activation and control system, such as electromagnetic or RF energy, infrared and other suitable remote 2 0 activation and control systems known in the art. By remotely, applicant means the actuators) are actuated or activated in response to the activation system or signals in a manner such that the actuator and activation system/signal generator need not be in direct physical or intimate contact. Preferably, the activation system/signal generator is located external to the body cavity into which the stmt is implanted. For example, Mossivand, et 2 5 al. describe an infrared (IR) remote communication system for use with an implantable ventricular assist device. A digital data stream is input into the system using standard transistor transistor logic (TTL) signal levels of 0-5 V. The digital signal is converted into a sinusoidal signal, which is fed into an IR transmitter driver, which converts the electrical signal into a modulating IR light signal directed towards IR receivers on the other side of the skin and tissue barrier. An IR receiver inside the body picks up this IR
light signal and converts it back into a sinusoidal data stream, which is then utilized by the ventricular assist device. Similarly, methods for radio frequency transmission of energy into the body via remote means have been described, (Schuder, et al. IEEE Trans. Biomed.
Eng.
18:265-273, 1971; Mussivand et al.). It is contemplated that persons skilled in the art can use and adapt these known techniques to design a remote control device to remotely activate the actuators) in the stmt to cause radial expansion or compression thereof.
As illustrated in FIGURES 2-4, the stmt 10 of the present invention is prepared for insertion into a body lumen 18 requiring physical radial support by adjusting the size of the main body 12 of the stmt 10. The body lumen 18 illustrated includes an area of stenosis 20 requiring treatment. In the preferred embodiment, the stmt 10 is prepared for insertion into the body lumen 18 by actuating the expansion/contraction elements 16 via the actuators 14; so as to apply radial pressure to the main body portion 12 associated therewith, thus reducing the radial dimension of the stmt. This reduction is carried out until the longitudinal length of the stmt 10 is small enough in radial dimension to allow 2 0 the stmt 10 to pass through the path of the body lumen 18 and be positioned.
In the second embodiment, in which the stmt 10 is manufactured and sized to have its smallest radial dimension when in a completely relaxed state, the natural state of the stent 10 exhibits the smallest radial dimension in size and thus no actuation of the expansion/contraction elements 16 by the actuators) is required.

The stmt 10 is guided into the proper position within the body lumen 18 via a guidewire 22 or like device such as described in U.S. Patent No. 4,754,752, or as known in the art. Although a guidewire device is disclosed herein, it is noted that the stent 10 can be guided into proper position within a body lumen 18 using any appropriate device, as for example, a catheter system, also described in U.S. Patent No. 4,754,752.
Now referring to FIGURE 3, once the stmt 10 is in place within the body lumen 18, the guidewire 22 is removed and the main body portion 12 is expanded to provide radial support to the stenotic area 22 of the body lumen 18. This is accomplished via the remote transmitter sending an RF electromagnetic signal, or other suitable signal, to the actuator 14, which responsively activates the expansion/contraction element 16 to adjust the radial force applied to the main body portion 12 of the stmt 10. In the preferred embodiment, as such radial force decreases, the generally shape-retaining nature of the material of the stmt 10 naturally expands to increase the radial dimension of the main body portion 12 of the stmt 10. Depending upon the needs of the patient, the condition of the body lumen 18 requiring support, and like factors, the main body portion 12 of the stmt 10 is expanded slightly or, alternatively, to its full radial dimension to provide the needed radial support. As can be seen in FIGURE 4, the stmt 10 is configured to provide maximum radial support to the body lumen 18. Once the stmt 10 is in the initial configuration (FIGURE 3) the insertion procedure is complete. Subsequently, to avoid 2 0 discomfort to, injury or rupture of the body lumen 18, the stmt 10 can be expanded incrementally over a prolonged period of time via the remote activation system, while providing the maximum radial support to the body lumen 18. Additionally, adjustments to the configuration of the stmt 10 can be made without re-entering or otherwise invasively accessing the body lumen 18. This feature of the stmt 10 allows, for example, a physician 2 5 or other medical personnel to expand or contract the main body portion 12 of the stmt 10 in the event the stmt 10 becomes crimped or otherwise adversely affected through activity or changing medical condition without the need for invasive surgical procedures.
The second embodiment described herein operates identically to the preferred embodiment, except that the expansion/contraction elements 16 of the stmt 10 of the second embodiment apply radially outward forces from within the main body portion 12 of the stmt 10 to increase the stmt's radial dimension.
Although preferred embodiments of the invention have been illustrated in the accompanying drawings and described in the foregoing Detailed Description, it will be understood that the invention is not limited to the embodiments disclosed, but is capable of modification without departing from the spirit of the invention.

Claims (5)

  1. I claim:

    A stent remotely and non-invasively adjustable when the stent is implanted in a living animal comprising:
    a tubular body portion defining a longitudinal length, a hollow interior and an exterior surface;
    one or more expansion/contraction elements located along said longitudinal length of said body portion; and one or more actuators operatively associated with said one or more expansion/contraction elements, wherein said actuators are remotely responsive to an activation signal from a control source remote from said one or more actuators for operatively actuating said one or more expansion/contraction elements for increasing or decreasing the radial dimension of said body portion of said stent.
  2. 2. A system for remotely controlling the radial dimension of a stent implanted in a living animal, comprising:
    a stent remotely adjustable when the stent is implanted in a living animal comprising:
    a tubular body portion defining a longitudinal length, a hollow interior and an exterior surface;
    one or more expansion/contraction elements located along said longitudinal length of said body portion; and one or more actuators operatively associated with said one or more expansion/contraction elements; and a control source for transmitting an activation signal, said control source located remote from and external to said one or more actuators;

    wherein said actuators are responsive to an activation signal from said remotely located control source; and whereby the expansion and contraction of said stent are remotely adjusted by means of said remotely located control source.
  3. 3. The system of claim 2, wherein said control source comprises a source of electromagnetic radiation and means of transmission thereof.
  4. 4. The system of claim 2, wherein said source comprises an infrared source.
  5. 5. The system of claim 2, wherein said source comprises a radio-frequency energy source.
CA002280416A 1997-05-13 1999-08-16 Remotely operable stent Abandoned CA2280416A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
US09/046,175 US5972029A (en) 1997-05-13 1998-03-23 Remotely operable stent
EP99650069A EP1077049A1 (en) 1998-03-23 1999-08-16 Remotely operable stent
JP22990699A JP3169943B2 (en) 1998-03-23 1999-08-16 Teleoperable stent
CA002280416A CA2280416A1 (en) 1998-03-23 1999-08-16 Remotely operable stent

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US09/046,175 US5972029A (en) 1997-05-13 1998-03-23 Remotely operable stent
EP99650069A EP1077049A1 (en) 1998-03-23 1999-08-16 Remotely operable stent
JP22990699A JP3169943B2 (en) 1998-03-23 1999-08-16 Teleoperable stent
CA002280416A CA2280416A1 (en) 1998-03-23 1999-08-16 Remotely operable stent

Publications (1)

Publication Number Publication Date
CA2280416A1 true CA2280416A1 (en) 2001-02-16

Family

ID=27427537

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002280416A Abandoned CA2280416A1 (en) 1997-05-13 1999-08-16 Remotely operable stent

Country Status (4)

Country Link
US (1) US5972029A (en)
EP (1) EP1077049A1 (en)
JP (1) JP3169943B2 (en)
CA (1) CA2280416A1 (en)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8790391B2 (en) * 1997-04-18 2014-07-29 Cordis Corporation Methods and devices for delivering therapeutic agents to target vessels
US6350277B1 (en) 1999-01-15 2002-02-26 Scimed Life Systems, Inc. Stents with temporary retaining bands
US6896690B1 (en) 2000-01-27 2005-05-24 Viacor, Inc. Cardiac valve procedure methods and devices
US6170488B1 (en) * 1999-03-24 2001-01-09 The B. F. Goodrich Company Acoustic-based remotely interrogated diagnostic implant device and system
US6206835B1 (en) 1999-03-24 2001-03-27 The B. F. Goodrich Company Remotely interrogated diagnostic implant device with electrically passive sensor
US6308715B1 (en) 1999-03-24 2001-10-30 Pmd Holdings Corp. Ultrasonic detection of restenosis in stents
US6317615B1 (en) 1999-04-19 2001-11-13 Cardiac Pacemakers, Inc. Method and system for reducing arterial restenosis in the presence of an intravascular stent
US7749245B2 (en) * 2000-01-27 2010-07-06 Medtronic, Inc. Cardiac valve procedure methods and devices
US9522217B2 (en) 2000-03-15 2016-12-20 Orbusneich Medical, Inc. Medical device with coating for capturing genetically-altered cells and methods for using same
US8088060B2 (en) 2000-03-15 2012-01-03 Orbusneich Medical, Inc. Progenitor endothelial cell capturing with a drug eluting implantable medical device
US6764505B1 (en) 2001-04-12 2004-07-20 Advanced Cardiovascular Systems, Inc. Variable surface area stent
US20040225326A1 (en) * 2001-05-07 2004-11-11 Weiner Mike L. Apparatus for the detection of restenosis
US7862495B2 (en) 2001-05-31 2011-01-04 Advanced Cardiovascular Systems, Inc. Radiation or drug delivery source with activity gradient to minimize edge effects
US6626940B2 (en) 2001-06-15 2003-09-30 Scimed Life Systems, Inc. Medical device activation system
US7493162B2 (en) 2001-06-15 2009-02-17 Cardiac Pacemakers, Inc. Pulmonary vein stent for treating atrial fibrillation
US6656216B1 (en) 2001-06-29 2003-12-02 Advanced Cardiovascular Systems, Inc. Composite stent with regioselective material
US7097658B2 (en) * 2001-08-22 2006-08-29 Hasan Semih Oktay Flexible MEMS actuated controlled expansion stent
US7223282B1 (en) 2001-09-27 2007-05-29 Advanced Cardiovascular Systems, Inc. Remote activation of an implantable device
US20030065386A1 (en) * 2001-09-28 2003-04-03 Weadock Kevin Shaun Radially expandable endoprosthesis device with two-stage deployment
US7236821B2 (en) * 2002-02-19 2007-06-26 Cardiac Pacemakers, Inc. Chronically-implanted device for sensing and therapy
US7169178B1 (en) 2002-11-12 2007-01-30 Advanced Cardiovascular Systems, Inc. Stent with drug coating
WO2005032413A2 (en) * 2003-09-30 2005-04-14 Alveolus Inc. Active stent
US7198675B2 (en) 2003-09-30 2007-04-03 Advanced Cardiovascular Systems Stent mandrel fixture and method for selectively coating surfaces of a stent
US8915957B2 (en) * 2004-03-11 2014-12-23 Alcatel Lucent Drug delivery stent
US7567841B2 (en) 2004-08-20 2009-07-28 Cardiac Pacemakers, Inc. Method and apparatus for delivering combined electrical and drug therapies
US8750983B2 (en) 2004-09-20 2014-06-10 P Tech, Llc Therapeutic system
US7887579B2 (en) 2004-09-29 2011-02-15 Merit Medical Systems, Inc. Active stent
US7499748B2 (en) 2005-04-11 2009-03-03 Cardiac Pacemakers, Inc. Transvascular neural stimulation device
US7617003B2 (en) 2005-05-16 2009-11-10 Cardiac Pacemakers, Inc. System for selective activation of a nerve trunk using a transvascular reshaping lead
WO2007029252A2 (en) * 2005-09-06 2007-03-15 Vital Valve (Israel) Ltd. Method and device for treatment of congestive heart failure and valve dysfunction
US8211088B2 (en) 2005-10-14 2012-07-03 Boston Scientific Scimed, Inc. Catheter with controlled lumen recovery
US7616990B2 (en) 2005-10-24 2009-11-10 Cardiac Pacemakers, Inc. Implantable and rechargeable neural stimulator
US7867547B2 (en) 2005-12-19 2011-01-11 Advanced Cardiovascular Systems, Inc. Selectively coating luminal surfaces of stents
US8069814B2 (en) 2006-05-04 2011-12-06 Advanced Cardiovascular Systems, Inc. Stent support devices
US8603530B2 (en) 2006-06-14 2013-12-10 Abbott Cardiovascular Systems Inc. Nanoshell therapy
US8048448B2 (en) 2006-06-15 2011-11-01 Abbott Cardiovascular Systems Inc. Nanoshells for drug delivery
US8017237B2 (en) 2006-06-23 2011-09-13 Abbott Cardiovascular Systems, Inc. Nanoshells on polymers
US9585743B2 (en) 2006-07-31 2017-03-07 Edwards Lifesciences Cardiaq Llc Surgical implant devices and methods for their manufacture and use
US9408607B2 (en) 2009-07-02 2016-08-09 Edwards Lifesciences Cardiaq Llc Surgical implant devices and methods for their manufacture and use
WO2008016578A2 (en) * 2006-07-31 2008-02-07 Cartledge Richard G Sealable endovascular implants and methods for their use
WO2008028037A2 (en) * 2006-08-30 2008-03-06 Andrew Young Distender device and method for treatment of obesity and metabolic and other diseases
US8048441B2 (en) 2007-06-25 2011-11-01 Abbott Cardiovascular Systems, Inc. Nanobead releasing medical devices
US9566178B2 (en) 2010-06-24 2017-02-14 Edwards Lifesciences Cardiaq Llc Actively controllable stent, stent graft, heart valve and method of controlling same
US9814611B2 (en) 2007-07-31 2017-11-14 Edwards Lifesciences Cardiaq Llc Actively controllable stent, stent graft, heart valve and method of controlling same
US20130211489A1 (en) * 2010-02-10 2013-08-15 Apertomed L.L.C. Methods, Systems and Devices for Treatment of Cerebrospinal Venous Insufficiency and Multiple Sclerosis
US20120130468A1 (en) 2010-07-27 2012-05-24 Fred Khosravi Methods and apparatus for treating neurovascular venous outflow obstruction
US8558489B2 (en) 2010-12-02 2013-10-15 Raytheon Company Micro motor
US9827093B2 (en) 2011-10-21 2017-11-28 Edwards Lifesciences Cardiaq Llc Actively controllable stent, stent graft, heart valve and method of controlling same
US10603195B1 (en) 2015-05-20 2020-03-31 Paul Sherburne Radial expansion and contraction features of medical devices
US11291568B2 (en) 2017-08-29 2022-04-05 C.R. Bard, Inc. Reconfigurable stent, and systems and methods for use thereof
WO2023046455A1 (en) * 2021-09-22 2023-03-30 Koninklijke Philips N.V. Imaging based reperfusion therapy monitoring devices, systems, and methods

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4754752A (en) * 1986-07-28 1988-07-05 Robert Ginsburg Vascular catheter
US5190540A (en) * 1990-06-08 1993-03-02 Cardiovascular & Interventional Research Consultants, Inc. Thermal balloon angioplasty
US5412265A (en) * 1993-04-05 1995-05-02 Ford Motor Company Planar micro-motor and method of fabrication
US5716410A (en) * 1993-04-30 1998-02-10 Scimed Life Systems, Inc. Temporary stent and method of use
IL105828A (en) * 1993-05-28 1999-06-20 Medinol Ltd Medical stent
US5406158A (en) * 1993-07-23 1995-04-11 Eaton Corporation Miniature synchronous motor
WO1995007109A1 (en) * 1993-09-10 1995-03-16 Ottawa Heart Institute Research Corporation Electrohydraulic ventricular assist device
US5476505A (en) * 1993-11-18 1995-12-19 Advanced Cardiovascular Systems, Inc. Coiled stent and delivery system
US5676685A (en) * 1995-06-22 1997-10-14 Razavi; Ali Temporary stent

Also Published As

Publication number Publication date
JP2001046511A (en) 2001-02-20
JP3169943B2 (en) 2001-05-28
US5972029A (en) 1999-10-26
EP1077049A1 (en) 2001-02-21

Similar Documents

Publication Publication Date Title
US5972029A (en) Remotely operable stent
US5221261A (en) Radially expandable fixation member
US5071407A (en) Radially expandable fixation member
US9526641B2 (en) Self constraining radially expandable medical devices
US5649978A (en) Temporary inflatable intravascular prosthesis
JP2940859B2 (en) Shape memory lock mechanism for intravascular stent
US6319275B1 (en) Endolumenal prosthesis delivery assembly and method of use
EP0820259B1 (en) Rolling membrane stent delivery device
AU726548B2 (en) Contraceptive system and method of use
AU2005253930B2 (en) Interfacial stent and method of maintaining patency of surgical fenestrations
US20090171448A1 (en) Implantable device with miniature rotating portion for energy harvesting
US20120035701A1 (en) Stent strut appositioner
US20230225736A1 (en) Vascular Flow and Pressure Modulator
JP2008502441A (en) Stent delivery system
JP2007513743A (en) Removable stent / graft
WO2011011787A2 (en) Interfacial stent and method of maintaining patency of surgical fenestrations
JPH03155869A (en) Stent and stent introducing catheter
WO2011084342A1 (en) Delivery system with retractable proximal end
EP0984741B1 (en) A modular prosthetic conduit
WO2007112064A2 (en) Conformable vascular prosthesis delivery system
MXPA99007537A (en) Remotely operable insertion device
KR20010017846A (en) Remotely Operable Stent
EP1493401B1 (en) Hybrid stent apparatus
CN211271434U (en) Prevent displacement detachable ureter metal tectorial membrane support
CA1274740A (en) Intravascular stent and percutaneous catheter system

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead